Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk

Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk The number of non-Hodgkin lymphoma (NHL) cases is rising, with an estimated 81,560 new diagnoses in the US in 2021. As survival rates improve, more NHL survivors face potential late effects, including secondary malignancies (SM) linked to treatments like chemotherapy and radiation. This research revisits

Childhood Obesity: Targeted Dietary Interventions

Childhood Obesity: Targeted Dietary Interventions Childhood obesity is a global concern, and dietary interventions have shown varying effectiveness in reducing BMI in children and adolescents. However, there is little guidance on targeted dietary approaches and energy reduction, leading to inconsistent recommendations. This excellent systematic review aimed to assess the effectiveness of

COPD Risk With Diabetes And Pre-Diabetes

COPD Risk With Diabetes And Pre-Diabetes A new trail-blazing study links diabetes, pre-diabetic states, and an extended duration of diabetes to an increased risk of chronic obstructive pulmonary disease development. This article will explore this ground-breaking research and its findings. Background of the Study Diabetes and chronic obstructive pulmonary diseases (COPD) are among

Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases

Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases Pain management is central to the medical practice of many medical professionals, especially rheumatologists and pain experts. Pain intensity has important implications, as it often indicates the severity of a disease, its prognosis, and the outcome of specific treatments. Also, evidence shows

The Impact Of Long-term Opioid Treatment On Endocrine Parameters

The Impact Of Long-term Opioid Treatment On Endocrine Parameters The injudicious use of opioids has always been a significant concern for health practitioners. It is due to the propensity of users to develop a dependence on these medications and the debilitating adverse effects associated with extended use of opioids. New research

Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk